In this short talk Dr. Harch reviews COVID-19 infection, the virus, the clinical course, deterioration of patients, laboratory findings, and the pathology in the lungs. He characterizes the lung injury as a wound in the lungs with primary problems of inflammation and low oxygen levels. He then shows how similar infection/wound diagnoses with inflammation and low oxygen levels have been successfully treated with hyperbaric oxygen.
Dr. Harch reviews the Chinese experience of HBOT with COVID-19 infection based on extensive communication with the treating Chinese doctors and the evolution of his presentation of this information on the internet. He discusses the different doses of HBOT, the Chinese data, the similar experience with HBOT in Spanish Flu victims in 1918, and the current HBOT COVID clinical trials registered on ClinicalTrials.gov.
